161 - 170 of 7876 Results
Title
Year
-
OPENTitle: Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALSJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 1771End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-02937-4Best OA location URL: https://www.nature.com/articles/s41591-024-02937-4.pdfCitation Count: 6
-
OPENTitle: RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analysesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 6Start Page: 603End Page: 614Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(24)00121-2Best OA location URL: http://www.thelancet.com/article/S1474442224001212/pdfCitation Count: 8
-
OPENTitle: Alpha-synuclein aggregates are phosphatase resistantJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-024-01785-0Citation Count: 1
-
OPENTitle: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synucleinJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49016-3Best OA location URL: https://www.nature.com/articles/s41467-024-49016-3.pdfCitation Count: 1
-
OPENTitle: Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) CellsJournal Name: BiomoleculesPublisher: MDPI AGVol: 14Issue #: 6Start Page: 647End Page: 647Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom14060647Citation Count: 0
-
OPENTitle: Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 8Start Page: 983End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14089Best OA location URL: https://doi.org/10.1002/mdc3.14089Citation Count: 1
-
OPENTitle: High-Yield α-Synuclein Purification and Ionic Strength Modification Pivotal to Seed Amplification Assay Performance and ReproducibilityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 11Start Page: 5988End Page: 5988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25115988Citation Count: 0
- Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease2024OPENTitle: Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00719-wCitation Count: 0
-
OPENTitle: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in modelJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-63130-8Citation Count: 0
-
OPENTitle: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variantJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 6Start Page: 1996End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae073Citation Count: 0